Henrik Kristian Moltke
Directeur/Membre du Conseil chez INITIATOR PHARMA A/S
Profil
Henrik Kristian Moltke is currently the Chairman at Dermaveris ApS, Werner Richter Og Hustrus Legat, StemCare A, StemCare Danmark A, and Initiator Pharma A.
He previously served as the Chief Executive Officer at EntomoPharm ApS, Director-Investor Relations & Communications at NTG Nordic Transport Group A, Director at Sjælsø Gruppen A, Director at Hartmanns A, Independent Director at Biosergen AB, Chief Financial Officer & Executive Vice President at Astion Pharma A, Chief Financial Officer at Fluxome Sciences A and Acesion Pharma ApS, Senior Vice President at Allarity Therapeutics A, and Chief Financial Officer at FluoGuide A.
Mr. Moltke holds a graduate degree from Copenhagen Business School.
Postes actifs de Henrik Kristian Moltke
| Sociétés | Poste | Début |
|---|---|---|
| INITIATOR PHARMA A/S | Directeur/Membre du Conseil | 01/01/2016 |
| Dermaveris ApS | Président | - |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Directeur/Membre du Conseil | - |
| StemCare Danmark A/S | Directeur/Membre du Conseil | - |
| Werner Richter Og Hustrus Legat | Président | - |
Anciens postes connus de Henrik Kristian Moltke
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSERGEN AB | Directeur/Membre du Conseil | 14/06/2024 |
| FLUOGUIDE A/S | Directeur Financier/CFO | 15/11/2022 |
Hartmanns A/S
 Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark. | Directeur/Membre du Conseil | 01/06/2022 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur Financier/CFO | 04/11/2020 |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Henrik Kristian Moltke
| Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| INITIATOR PHARMA A/S | Health Technology |
| FLUOGUIDE A/S | Health Technology |
| BIOSERGEN AB | Health Technology |
| Entreprise privées | 11 |
|---|---|
Sjælsø Gruppen A/S
 Sjælsø Gruppen A/S Financial ConglomeratesFinance Sjælsø Gruppen A/S engages in the trade and investment activities related to real estate. The firm develops real estate properties and also leases businesses, retail, and residential projects for owners, tenants, and investors. The company was founded by Ib Henrik Ronje and Torben Ronje on October 1, 1977 and is headquartered in Allerød, Denmark. | Finance |
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |
Fluxome Sciences A/S
 Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Health Technology |
Hartmanns A/S
Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark. | Commercial Services |
EntomoPharm ApS
 EntomoPharm ApS Pharmaceuticals: MajorHealth Technology EntomoPharm ApS is a holding company that develops insect based absorption, distribution, metabolism, or excretion (ADME) models for early drug discovery. It is a contract research organization that offers validated ex vivo blood brain barrier screening model providing customized study design. Its insect assays can be used to screen small-molecule compounds to identify properties of drug leads in both central nervous system drug development and in safety risk identification for peripherally acting drugs. The firm provides models based on the locust migratory to determine the permeability; the in vivo and the ex vivo model. The company was founded by Peter Aadal Nielsen and Gunnar Andersson in 2009 and is headquartered in Hillerod, Denmark. | Health Technology |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Dermaveris ApS | |
| StemCare Danmark A/S | |
| Werner Richter Og Hustrus Legat | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
